Diversity Planning Belongs in Protocol Design, Not the Enrollment Crisis Meeting
A new pilot shows early diversity planning cuts mid-trial amendments, here's what that means for site selection, IRT setup,...
A new pilot shows early diversity planning cuts mid-trial amendments, here's what that means for site selection, IRT setup,...
The Lancet calls out "hard to reach" as a stigmatizing label. For clinical ops, it's a site selection failure...
ASCO and Ryght AI are using algorithms to select CDK4/6 inhibitor trial sites. Here's what ops teams need to...
ASCO and Ryght AI are using machine learning to select breast cancer trial sites. Here's what that means for...
During the recent SCOPE Summit Europe 2023, a venue for experts to dissect the complexities of clinical trials, Kieran...